India · Delayed Price · Currency is INR Crop Life Science Statistics
Total Valuation
NSE:CLSL has a market cap or net worth of INR 888.71 million. The enterprise value is 1.49 billion.
| Market Cap | 888.71M |
| Enterprise Value | 1.49B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:CLSL has 17.14 million shares outstanding. The number of shares has decreased by -5.12% in one year.
| Current Share Class | 17.14M |
| Shares Outstanding | 17.14M |
| Shares Change (YoY) | -5.12% |
| Shares Change (QoQ) | -39.06% |
| Owned by Insiders (%) | 35.84% |
| Owned by Institutions (%) | n/a |
| Float | 11.00M |
Valuation Ratios
The trailing PE ratio is 12.56.
| PE Ratio | 12.56 |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.00, with an EV/FCF ratio of -10.62.
| EV / Earnings | 25.54 |
| EV / Sales | 0.69 |
| EV / EBITDA | 9.00 |
| EV / EBIT | 13.13 |
| EV / FCF | -10.62 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.46 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.54 |
| Debt / FCF | -4.18 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is 6.92% and return on invested capital (ROIC) is 5.71%.
| Return on Equity (ROE) | 6.92% |
| Return on Assets (ROA) | 3.12% |
| Return on Invested Capital (ROIC) | 5.71% |
| Return on Capital Employed (ROCE) | 12.37% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | 10.22M |
| Profits Per Employee | 277,314 |
| Employee Count | 210 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 2.51 |
Taxes
In the past 12 months, NSE:CLSL has paid 23.29 million in taxes.
| Income Tax | 23.29M |
| Effective Tax Rate | 29.26% |
Stock Price Statistics
The stock price has increased by +1.67% in the last 52 weeks. The beta is 0.05, so NSE:CLSL's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +1.67% |
| 50-Day Moving Average | 51.43 |
| 200-Day Moving Average | 51.93 |
| Relative Strength Index (RSI) | 58.89 |
| Average Volume (20 Days) | 17,400 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:CLSL had revenue of INR 2.15 billion and earned 58.24 million in profits. Earnings per share was 4.13.
| Revenue | 2.15B |
| Gross Profit | 607.66M |
| Operating Income | 113.27M |
| Pretax Income | 79.60M |
| Net Income | 58.24M |
| EBITDA | 154.74M |
| EBIT | 113.27M |
| Earnings Per Share (EPS) | 4.13 |
Balance Sheet
The company has 22.41 million in cash and 584.38 million in debt, with a net cash position of -561.97 million or -32.79 per share.
| Cash & Cash Equivalents | 22.41M |
| Total Debt | 584.38M |
| Net Cash | -561.97M |
| Net Cash Per Share | -32.79 |
| Equity (Book Value) | 841.52M |
| Book Value Per Share | 60.79 |
| Working Capital | 587.50M |
Cash Flow
In the last 12 months, operating cash flow was -98.16 million and capital expenditures -41.81 million, giving a free cash flow of -139.97 million.
| Operating Cash Flow | -98.16M |
| Capital Expenditures | -41.81M |
| Free Cash Flow | -139.97M |
| FCF Per Share | -8.17 |
Margins
Gross margin is 28.32%, with operating and profit margins of 5.28% and 2.71%.
| Gross Margin | 28.32% |
| Operating Margin | 5.28% |
| Pretax Margin | 3.71% |
| Profit Margin | 2.71% |
| EBITDA Margin | 7.21% |
| EBIT Margin | 5.28% |
| FCF Margin | n/a |
Dividends & Yields
NSE:CLSL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.12% |
| Shareholder Yield | 5.12% |
| Earnings Yield | 6.55% |
| FCF Yield | -15.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NSE:CLSL has an Altman Z-Score of 2.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.26 |
| Piotroski F-Score | 2 |